These four tests are screening rows. The catalogue does not call them confirmatory assays, and the report does not add a sentence the laboratory did not type.
- HIV 1 and 2 antibodies, serum, opening price ₹450, one row, default Non-Reactive.
- HBsAg, serum, ₹400, default Non-Reactive.
- Anti-HCV, serum, ₹600, default Non-Reactive.
- VDRL or RPR, serum, ₹200, default Non-Reactive, plus a titre row that opens as a dash.
Change Non-Reactive when the run is reactive. Because the row is text, there is no high/low flag on it. The words on the paper are the words typed at result entry.
A reactive screening line is still not a completed clinical opinion. The printed page can carry a short remark under the parameter, and clinical notes if someone types them. Those notes already print with a line that they are for correlation and are not a diagnosis. Anything beyond that is the laboratory’s own text.
Widal sits in this same department. It is described with dengue and malaria because that is how it is usually ordered.